Consumer Alert
Three companies that tout their cannabis-derived products as miracle treatments for serious illnesses have gotten letters from the FTC warning that they’re at risk for legal action unless they have sound scientific evidence to back up their claims. The companies sell oils, capsules, edible gummies, and creams that contain cannabidiol (CBD), a chemical compound derived from the cannabis plant.
One company claims that CBD works like “magic” to relieve even the most agonizing pain. The company claims CBD has been clinically proven to treat diseases including cancer, Alzheimer’s disease, and multiple sclerosis. The second company’s website says CBD products are proven to treat twenty health conditions, including autism, anorexia, cancer, and AIDS. The third company’s site promotes CBD edible gummies as highly effective at treating the root cause of most major degenerative diseases. It also claims its CBD cream relieves pain and that its CBD oil may effectively treat depression, PTSD, epilepsy, and other diseases.
This week, the FTC sent letters that urge the companies to review all claims — including consumer testimonials — made for their products, to ensure they’re backed by competent and reliable scientific evidence. The letters tell the companies to notify the FTC within 15 days of the specific actions they have taken to address the agency’s concerns.
Talk with your doctor before you try a healthcare product you find online. Find out about the product’s risks, side effects, and possible interactions with any medications you’re taking
Search Terms
Topics
33 Comments
Read Our Privacy Act Statement
It is your choice whether to submit a comment. If you do, you must create a user name, or we will not post your comment. The Federal Trade Commission Act authorizes this information collection for purposes of managing online comments. Comments and user names are part of the Federal Trade Commission’s (FTC) public records system, and user names also are part of the FTC’s computer user records system. We may routinely use these records as described in the FTC’s Privacy Act system notices. For more information on how the FTC handles information that we collect, please read our privacy policy.
Comment Policy
This is a moderated blog; we review all comments before they are posted. We expect participants to treat each other and the bloggers with respect. We will not post comments that do not comply with our commenting policy. We may edit comments to remove links to commercial websites or personal information before posting them.
We won’t post:
Comments submitted to this blog become part of the public domain. To protect your privacy and the privacy of others, please do not include personal information. Also, do not use this blog to report fraud; instead, file a complaint.